Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002453
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2000-01-24
Brief Title:
A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
An Open-Label Multicenter Compassionate Access Study of the Safety of Tenofovir Disoproxil Fumarate Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Patients
Status:
COMPLETED
Status Verified Date:
2000-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study allows patients who need a new anti-HIV treatment to take tenofovir disoproxil fumarate tenofovir DF an experimental drug This study also looks at any side effects the drug causes
Detailed Description:
HIV-1-infected patients who are currently receiving stable antiretroviral therapy add tenofovir DF to their regimen Study participation lasts for approximately 48 weeks Interested patients should contact their physicians
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GS-99-908 | None | None | None |